Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of An Angiotensin Receptor Blocker to Hepatic Stellate Cells in RatsMontserrat Moreno, Ramón Bataller, Teresa Gonzalo et al.|Hepatology|2009Cited by 133
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cellsIşıl Altıntaş, Robbert J. Kok, Raimond Heukers et al.|Journal of Controlled Release|2012Cited by 115
Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate CellsTeresa Gonzalo, Robbert J. Kok, László Őrfi et al.|Journal of Pharmacology and Experimental Therapeutics|2007Cited by 78
Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1 H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal FibrosisJai Prakash, Robbert J. Kok, Maria Sandovici et al.|Journal of Pharmacology and Experimental Therapeutics|2006Cited by 57
Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal FibrosisJai Prakash, Robbert J. Kok, Martin H. de Borst et al.|Pharmaceutical Research|2008Cited by 46